Vanda Pharmaceuticals (VNDA) Non-Current Assets (2010 - 2026)
Vanda Pharmaceuticals' Non-Current Assets was $147.98 million in Q2 2026, down 35.6% from $229.83 million a year earlier but up 5.4% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Vanda Pharmaceuticals came in at $141.69 million, down 34.8% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $217.31 million in FY2024 (+0.8%), $215.49 million in FY2023 (+87.5%), $114.96 million in FY2022 (-0.5%) and $115.49 million in FY2021 (-7.1%).
- Quarterly Non-Current Assets has moved between $105.03 million (Q3 2023) and $233.64 million (Q3 2025) over five years.
- Compared with a year earlier, Non-Current Assets has declined for three straight quarters, with growth averaging 2.4% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q3 2024 (growth of 102.5%); the worst was Q1 2026 (a decline of 37.3%).
- Per Business Quant data, VNDA's Non-Current Assets in the three quarters before Q2 2026 was $140.36 million (Q1 2026), $141.69 million (Q4 2025) and $233.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Vanda Pharmaceuticals | 304.09 Mn | -625.85 Mn | 46.97 Mn | 147.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 147.98 Mn |
| Mar 31, 2026 | 140.36 Mn |
| Dec 31, 2025 | 141.69 Mn |
| Sep 30, 2025 | 233.64 Mn |
| Jun 30, 2025 | 229.83 Mn |
| Mar 31, 2025 | 224.03 Mn |
| Dec 31, 2024 | 217.31 Mn |
| Sep 30, 2024 | 212.73 Mn |
| Jun 30, 2024 | 212.19 Mn |
| Mar 31, 2024 | 213.26 Mn |
| Dec 31, 2023 | 215.49 Mn |
| Sep 30, 2023 | 105.03 Mn |
| Jun 30, 2023 | 108.18 Mn |
| Mar 31, 2023 | 110.83 Mn |
| Dec 31, 2022 | 114.96 Mn |
| Sep 30, 2022 | 114.68 Mn |
| Jun 30, 2022 | 112.21 Mn |
| Mar 31, 2022 | 111.29 Mn |
| Dec 31, 2021 | 115.49 Mn |
| Sep 30, 2021 | 117.96 Mn |
API Access
Vanda Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();